Eton Pharmaceuticals (ETON) Profit After Tax: 2019-2025
Historic Profit After Tax for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to -$1.9 million.
- Eton Pharmaceuticals' Profit After Tax fell 407.34% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.7 million, marking a year-over-year decrease of 21.91%. This contributed to the annual value of -$3.8 million for FY2024, which is 308.44% down from last year.
- Eton Pharmaceuticals' Profit After Tax amounted to -$1.9 million in Q3 2025, which was up 25.45% from -$2.6 million recorded in Q2 2025.
- In the past 5 years, Eton Pharmaceuticals' Profit After Tax registered a high of $5.1 million during Q1 2021, and its lowest value of -$6.1 million during Q3 2021.
- Its 3-year average for Profit After Tax is -$985,727, with a median of -$1.6 million in 2025.
- As far as peak fluctuations go, Eton Pharmaceuticals' Profit After Tax soared by 392.62% in 2023, and later slumped by 407.34% in 2025.
- Quarterly analysis of 5 years shows Eton Pharmaceuticals' Profit After Tax stood at $1.0 million in 2021, then fell by 12.22% to $912,000 in 2022, then plummeted by 347.37% to -$2.3 million in 2023, then surged by 73.49% to -$598,000 in 2024, then crashed by 407.34% to -$1.9 million in 2025.
- Its Profit After Tax was -$1.9 million in Q3 2025, compared to -$2.6 million in Q2 2025 and -$1.6 million in Q1 2025.